|
Summary
March 2007, Vol. 2, No. 2, Pages 203-209
, DOI 10.2217/17460751.2.2.203
(doi:10.2217/17460751.2.2.203)
Perspective Why we should, in fact, pay for egg donationCharis Thompson In this perspective, I shall argue that women who donate eggs solely for human embryonic stem cell research ought to be compensated. My argument rests on three inter-related principles. First, it is important to recruit the healthiest possible egg donors to minimize the risks of donation. This would relieve pressure to donate on those suffering from diseases that might be treatable with stem cell-based therapies, who are likely to be at greater risk from donation. Second, I believe that it is crucial to be pro-active in building representative stem cell banks, especially in stem cell initiatives paid for, in part, by the public/government. The right of all groups to participate in and benefit from equitable and safe research must be developed for egg donors as for other kinds of research participants. Particular attention should be paid to the opinions and desires of women from historically underserved populations as to how to conduct donations and guide research so as to serve all members of society. Third, reasonable payment would undermine tendencies for domestic and international black and grey egg markets for stem cell research to develop. I then suggest replacing the question of compensation with the question of harm mitigation as the central donor protection issue.
Cited byKatherine Carroll, Catherine Waldby. (2011) Informed Consent and Fresh Egg Donation for Stem Cell Research. Journal of Bioethical InquiryOnline publication date: 23-Dec-2011. CrossRef Robin N. Fiore, Kathryn M. Hinsch. (2011) Oocytes for Research: Reevaluating Risks and Compensation. The American Journal of Bioethics 11:9, 42-43 Online publication date: 1-Sep-2011. CrossRef Catherine Waldby, Katherine Carroll. (2011) Egg donation for stem cell research: ideas of surplus and deficit in Australian IVF patients’ and reproductive donors’ accounts. Sociology of Health & Illnessno-no Online publication date: 1-Sep-2011. CrossRef Ruha Benjamin. (2011) Organized ambivalence: when sickle cell disease and stem cell research converge. Ethnicity & Health 16:4-5, 447-463 Online publication date: 1-Aug-2011. CrossRef W. Calvin Ho, Benjamin Capps, Teck Chuan Voo. (2010) Stem Cell Science and its Public: The Case of Singapore. East Asian Science, Technology and Society: an International Journal 4:1, 7-29 Online publication date: 1-Mar-2010. CrossRef (2009) The ethics of egg manipulation. Nature 460:7259, 1057-1057 Online publication date: 27-Aug-2009. CrossRef Robert Klitzman, Mark V Sauer. (2009) Payment of egg donors in stem cell research in the USA. Reproductive BioMedicine Online 18:5, 603-608 Online publication date: 1-Jan-2009. CrossRef Rob B.M. de Vries, Anke Oerlemans, Leen Trommelmans, Kris Dierickx, Bert Gordijn. (2008) Ethical Aspects of Tissue Engineering: A Review. Tissue Engineering Part B: Reviews 14:4, 367-375 Online publication date: 1-Dec-2008. CrossRef Donna Dickenson, Itziar Alkorta Idiakez. (2008) Ova donation for stem cell research: An international perspective. International Journal of Feminist Approaches to Bioethics 1:2, 125-144 Online publication date: 1-Oct-2008. CrossRef Adele E. Clarke. (2008) Introduction: Gender and Reproductive Technologies in East Asia. East Asian Science, Technology and Society: an International Journal 2:3, 303-326 Online publication date: 1-Sep-2008. CrossRef Boon Chin Heng. (2008) Suggested ethical guidelines and legislation for egg donation in Singapore. Expert Review of Obstetrics & Gynecology 3:2, 181-188 Online publication date: 1-Mar-2008. CrossRef Roberto S Oliveri. (2007) Epigenetic dedifferentiation of somatic cells into pluripotency: cellular alchemy in the age of regenerative medicine?. Regenerative Medicine 2:5, 795-816 Online publication date: 1-Sep-2007. Summary | Full Text | PDF (783 KB) | PDF Plus (766 KB)
|
Reprints & Permissions
|
|
|